As of Monday, August 15, drug companies can no longer bar comments from their Facebook pages. The conversation is now open, and Facebook users can freely comment on drugs, regardless of their knowledge and use of the drug in question.
Ostensibly, this seems fair. Drug companies should play by the same rules as the rest of companies, right? But if drug companies should abide by the same Facebook rules, they should be just as free from government regulation as are other companies whose pages feature third-party wall posts. Unfortunately, this is not the case. Comments on the walls of drug companies can expose drug companies to serious liability with the FDA – liability that could cost hundreds of millions of dollars. Continue reading “Facebook and FDA Put Drug Companies in Catch-22 Situation on Social Media”